Publication | Closed Access

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

MedicineMulticentric Double-blindSecond Primary TumoursOral CavityPathologyHead And Neck CancerOncologyRadiation OncologyCancer ResearchOral Cancer